Citigroup Inc Veru Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Veru Inc. stock. As of the latest transaction made, Citigroup Inc holds 103,641 shares of VERU stock, worth $69,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,641

Previous 65,169 59.03%

Holding current value

$69,439

Previous $54,000 46.3%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.77 - $1.04 $29,623 - $40,010	38,472 Added 59.03%	103,641 $79,000
Q2 2024 Aug 12, 2024	BUY	$0.76 - $1.79 $44,166 - $104,024	58,114 Added 823.73%	65,169 $54,000
Q1 2024 May 10, 2024	SELL	$0.37 - $0.72 $13,866 - $26,983	-37,477 Reduced 84.16%	7,055 $4,000
Q4 2023 Feb 09, 2024	BUY	$0.67 - $1.17 $24,981 - $43,624	37,286 Added 514.57%	44,532 $32,000
Q2 2023 Aug 10, 2023	SELL	$0.98 - $1.49 $1,372 - $2,086	-1,400 Reduced 16.19%	7,246 $8,000
Q1 2023 May 11, 2023	BUY	$1.16 - $6.41 $7,668 - $42,376	6,611 Added 324.86%	8,646 $10,000
Q4 2022 Feb 09, 2023	SELL	$4.78 - $15.01 $5,645 - $17,726	-1,181 Reduced 36.72%	2,035 $10,000
Q3 2022 Nov 10, 2022	SELL	$10.22 - $23.7 $37,967 - $88,045	-3,715 Reduced 53.6%	3,216 $37,000
Q2 2022 Aug 10, 2022	SELL	$4.35 - $15.85 $9,322 - $33,966	-2,143 Reduced 23.62%	6,931 $78,000
Q1 2022 May 12, 2022	SELL	$4.55 - $6.41 $42,810 - $60,311	-9,409 Reduced 50.91%	9,074 $44,000
Q4 2021 Feb 10, 2022	BUY	$5.89 - $9.73 $51,413 - $84,933	8,729 Added 89.49%	18,483 $109,000
Q3 2021 Nov 10, 2021	BUY	$6.78 - $9.89 $66,132 - $96,467	9,754 New	9,754 $83,000

Others Institutions Holding VERU

# of Institutions

123

Shares Held

56.9M

Call Options Held

668K

Put Options Held

531K

View Full List

About VERU INC.

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $53.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

More about VERU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account